Maternal B cell signaling orchestrates fetal development in mice.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
15 04 2022
Historique:
received: 06 05 2021
accepted: 25 08 2021
pubmed: 17 9 2021
medline: 3 2 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

B cell participation in early embryo/fetal development and the underlying molecular pathways have not been explored. To understand whether maternal B cell absence or impaired signaling interferes with placental and fetal growth, we paired CD19-deficient (CD19-/-) mice, females with B cell-specific MyD88 (BMyD88-/-) or IL10 (BIL10-/-) deficiency as well as wild-type and MyD88-/- controls on C57Bl/6 background with BALB/c males. Pregnancies were followed by ultrasound and Doppler measurements. Implantation number was reduced in BMyD88-/- and MyD88-/- mice. Loss of MyD88 or B cell-specific deletion of MyD88 or IL10 resulted in decreased implantation areas at gestational day (gd) 5, gd8 and gd10, accompanied by reduced placental thickness, diameter and areas at gd10. Uterine artery resistance was enhanced in BIL10-/- dams at gd10. Challenge with 0.4 mg lipopolysaccharide/kg bodyweight at gd16 revealed that BMyD88-/-, BIL10-/- and CD19-/- mothers delivered preterm, whereas controls maintained their pregnancy. B cell-specific MyD88 and IL10 expression is essential for appropriate in utero development. IL10+B cells are involved in uterine blood flow regulation during pregnancy. Finally, B cell-specific CD19, MyD88 and IL10 expression influences susceptibility towards preterm birth.

Identifiants

pubmed: 34528666
pii: 272200
doi: 10.1242/dev.199783
pii:
doi:

Substances chimiques

Antigens, CD19 0
CD19 antigen, mouse 0
IL10 protein, mouse 0
Myd88 protein, mouse 0
Myeloid Differentiation Factor 88 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Auteurs

Mandy Busse (M)

Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39108, Germany.

Stefanie Langwisch (S)

Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39108, Germany.

Kerry Tedford (K)

Institute for Biochemistry and Cell Biology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39112, Germany.

Klaus-Dieter Fischer (KD)

Institute for Biochemistry and Cell Biology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39112, Germany.

Ana Claudia Zenclussen (AC)

Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg 39108, Germany.
Department of Environmental Immunology, Helmholtz Centre for Environmental Research, Leipzig 04318, Germany.
Perinatal Research Group, Saxonian Incubator for Translation, Leipzig University, Leipzig 04103, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH